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ABSTRACT  
The present study describes the isolation and structural elucidation of new alkaloid 3-deoxy-3, 11-epoxy cephalotaxine (1) from the flowers of 
C. ternatea. It was isolated by careful column chromatographic separation of the crude extract on silica gel 60. The structure was established 
based on UV, IR, 1HNMR, 13CNMR and GC-MS spectroscopy methods. The antibacterial activity of various bacterial and fungal strains and anti-
inflammatory activities of the isolated compound and its crude methanol extract was studied. The highest zone of inhibition ( 13.0 and 12.0 mm) 
was shown by 1 at a dose of 200 µg/kg against E. coli and S. aureus strains and (16.0, 12.0 mm) against anti-fungal strains of C. albicans and A. 
flavus. The results indicated that at both dose levels (100 mg and 200 mg / kg) of isolated compound 1 had significant anti-inflammatory 
activity from 2nd hour onwards. The bioactive compound isolated from this plant can be employed for antimicrobial activity, also for the 
treatment of various bacterial and fungal infections and to show pronounced anti-inflammatory effects after three hours of injection.  
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INTRODUCTION 
The cephalotaxine was first described and reported in the 
genus cephalotaxus1. Homoerythrina alkaloids also present 
in Cephalotaxus extracts and that cephalotaxinone usually 
occurs as a minor constituent of C. harringtonia 2. Four 
Cephalotaxus alkaloids in lesser amounts, all closely related 
to esters of cephalotaxine, possess marked activity against 
experimental leukemia in mice 3, 4. Cephalotaxine consisting 
of five fused polycyclic rings have a novel arrangement 
which is unique in nature, i.e. a benzodiazepine onto which a 
spiro-pyrrolidine-pentanediol system is fused. The only 
reactive function is a secondary alcohol located at a third 
position. The methyl enol ether is located at a second 
position and is potentially sensitive to proton attack 5, 6. 
Considering all that, we did not find any previously 
published original articles about epoxy Cephalotaxine of C. 
ternatea and in order to provide a traditional medicinal 
value of this species, the present study was designed. The 
chemical composition and the biological activities such as 
antibacterial and anti-inflammatory activities of the 3-
deoxy-3, 11-epoxy Cephalotaxine (1) from the flowers of C. 
ternatea were evaluated and reported for the first time.  
C. ternatea (Fabaceae) is propagated through seeds. It is a 
perennial twining herb, commonly known as Butterfly pea 
with blue and white flowers 7. The whole plant is used in the 
treatment of chronic bronchitis, goiter, leprosy, mucous 
disorders, sight weakness, skin diseases, sore throat and 
tumors. It is also traditionally used for sexual ailments, like 
infertility and gonorrhea, to regulate the menstrual 
discharge and as an aphrodisiac 8. A wide range of secondary 
metabolites like alkaloids, triterpenoids, flavonol glycosides, 
anthocyanins, and steroids were isolated from C. ternatea 9. 
The objective of the present study describes the isolation, 
structural elucidation of the alkaloid obtained for the first 
time from the chloroform fraction of C. ternatea, further 
antimicrobial activity of the isolated compound against 
Gram-positive and Gram-negative bacteria by disc diffusion 
method and to establish its therapeutic potential in the 
treatment of anti-inflammatory activity in carrageenan 
induced paw edema bioassay in male albino rats. 
MATERIALS AND METHODS 
General  
Melting points were determined using SMP20 melting point 
apparatus (Fisher Scientific Ltd, UK) without correction. 
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Optical rotations were measured with a JASCO P-2000 
polarimeter (Tokyo, Japan). UV spectra were recorded on an 
ultraviolet spectrometer (UV-3010, Perkin Elmer, USA), IR 
spectra were measured on FT-IR spectrophotometer (PE 
1600, Perkin Elmer, USA) with KBr tablets from 4000 to 400 
cm−1 to resolution 2 cm−1.  Supporting evidence for the 
structure of the compound is provided by the 1H (CDCl3, 500 
MHz) and 13CNMR (500 MHz, CDCl3) spectra, which was 
recorded on Bruker AMX 500 instrument (Bruker Company, 
Faelladen, Switzerland). GC-MS analyses were performed on 
a Perkin Elmer Clarus 500 GC-MS system. The fused-silica 
HP-5 MS capillary column (30 m - 0.25 mm ID, the film 
thickness of 0.25 mm) was directly coupled to the MS.  
Column chromatography (CC) was performed on silica gel 
60 as stationary phase (particle size 0.04-0.036 mm, 230-
400 mesh, ASTM, E. Merck, Germany) and activated by 
heating at 110ºC for an hour prior to be used. TLC was 
performed on 0.25 mm Brinkman percolated silica gel 60 
F254 plates (silica gel, 60 / 230-400 meshes, Merck). 
Analytical plates were developed with the solvent system 
CHCl3-MeOH (9:1) and spots were visualized by spraying 
with bromothymol blue in EtOH.  
Plant material   
The beautiful blue flowers of C. ternatea, an ornamental 
plant was collected in the month of March from the family 
garden in and around Kumbakonam, Thanjavur District 
(India) and authenticated by Dr. N. Ramakrishnan, Head & 
Associate Professor, Department of Botany, Government 
Arts College (Autonomous), Kumbakonam, Tamilnadu, India 
and a voucher specimen (GACBOT-121) was deposited in the 
Herbarium of the Department of Botany for future reference. 
The flowers were air-dried under shade for extraction 
procedure and evaluation. 
Extraction and isolation 
The air-dried flowers (750 g) were extracted with 95% 
MeOH (6 x 500 mL) by cold percolation and soaked for 4 
days at room temperature (30±2°C). The suspension was 
stirred from time to time and then filtered using Whatman 
No.1. The MeOH extract was filtered and concentrated to 
dryness using a rotary evaporator under reduced pressure 
at a temperature of 45ºC for complete solvent removal. After 
that, the dried MeOH extract (30.4 g) was fractionated using 
petroleum ether in a simple column chromatography packed 
with silica gel (column grade). The petroleum ether extract 
was washed with 50 mL of 5 % aqueous hydrochloric acid. 
The aqueous layer was made basic to pH 10, by adding 
Na2CO3, and extracted with chloroform (5 x 100 mL). The 
chloroform extract was evaporated to dryness in vacuo to 
afford a brown amorphous material (11.50 g) and it was 
subjected to silica gel column chromatography (230 - 400 
mesh, 10 × 40 cm) with 500mL of ethyl acetate as eluents to 
afforded (1) (7.15 g, 62 %) which gave a single spot on TLC; 
Rf 0.85.  
Acute toxicity studies  
Acute toxicity studies were carried out male albino rats (200 
– 250 g) of Wistar strain, according to OECD (Organization 
for economic cooperation and development guidelines no. 
425, 2006). Test groups (each containing six animals) were 
received oral doses of 100, 200 and 300 mg/kg (p.o.) of 3 - 
deoxy - 3, 11- epoxy cephalotaxine and its MeOH extract, 
while the control group received the vehicle (saline). The 
groups were observed for 48 h and mortality (at the end of 
this period) was recorded in each group 10. The LD50 (50% 
lethal dose) was determined by probit test using the log of 
the dose versus probit 11. No adverse effect or mortality was 
observed during the period of the observation (48 h). Based 
on the study, respective doses were selected for further 
pharmacological evolution.  
 Anti-bacterial activity by Disc diffusion method  
Anti-bacterial activity was carried out by the method 
suggested by Bauer et al 12. Bacterial strains of Escherichia 
coli, Staphylococcus aureus and fungal strains of Aspergillus 
flavus, Candida albicans were obtained from Microbial Type 
Culture Collection Centre (MTCC), Chandigarh, India. The 
bacterial cultures were swabbed onto Muller Hinton agar 
media and autoclaved at 15 lbs pressure for 20 minutes and 
cooled to 45ºC. To the cooling medium 10 mL of L-tartaric 
acid (10 %) was added (anti-bacterial agent) and poured 
onto the sterile Petri plates and allowed for solidification. A 
total of 6 mm diameter wells was punched into the agar and 
filled with plant extracts along with control and standard 
(Ciprofloxacin and Amphotericin B; < 95 %, purchased from 
Sigma-Aldrich, India) discs. The plates were then incubated 
at 37°C for 48 hours. The antibacterial activity was evaluated 
by measuring the zone of inhibition and expressed in mm. 
Anti-inflammatory activity by Carrageenan induced rat 
paw edema  
The anti-inflammatory activity of the test compounds was 
evaluated in albino rats employing the method suggested by 
Diwan et al 13. Male albino rats (200 – 250 g) of Wistar strain 
were procured from the animal house of our college. 
Animals were fasted overnight and divided into control; 
standard and different test groups each consisting of six 
animals. The different test concentration (100 and 200 mg / 
kg of isolated compound 1, 300 mg/kg methanolic extract 
and 10 mg / kg diclofenac sodium (98 %, purchased from 
Sigma-Aldrich, India) was administered to the animals by 
the oral route. Control group animals were received 1% 
DMSO in sterile saline orally (10 mL/Kg). They are housed in 
cages and maintained under standard conditions (at 26 ± 
2°C, relative humidity of 60 – 65 %, 12 hours light and 14 
hours dark cycles a day) for one week. All animals were fed 
with the standard rodent pellet diet and UV purified and 
filtered water, ad libitum. Before starting the experiment on 
animals, the experimental protocol was subjected to the 
scrutiny of the Institutional Animal Ethics Committee (IAEC), 
Bharathidasan University, Trichirappalli, Tamilnadu, India 
(Approval No. BDU/IAEC/2011/31/29.03.2011). 
Acute inflammation was induced by the subplantar 
administration of 0.1 mL of 1 % carrageenan in the right 
paw. Paw volume was measured by using digital 
plethysmometer (Ugo Basile-Italy) before administration of 
carrageenan and after 1, 2, 3 and 4-hour intervals 14. The 
efficacy of the different drug was tested on its ability to 
inhibit paw edema as compared to control group. 
Volume of edema = Final Paw Volume - Initial Paw Volume 
The percentage inhibition of paw edema was calculated by 
the formula  
% Inhibition of Paw edema = [(VC – VT) / VC] x 100 
Where, VC = Paw edema of control group and VT = Paw 
edema of the treated group 
Statistical analysis  
The experimental results were expressed in multiple 
comparisons of Mean ± SEM and was carried out by one-way 
analysis of variance (ANOVA) followed by Dunnet Multiple 
Comparisons Test and statistical significance was defined as 
P < 0.05. 
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3-deoxy-3, 11-epoxy cephalotaxine (1) - Colorless needles 
(CHCl3); mp 158-160°C; Rf 0.85 (TLC); [α]20D : -59.0 (c = 0.30 
in CHCl3); UV (log ε) 240 - 288 nm; IR (KBr): νmax 
3288, 2982, 2835, 1646, 1448, 1230, 1107, 1060, 1015 and 
920 cm-1; M+ m/e : 312.97 (calcd for C18H19NO4 313.00). 
Supporting evidence for the structure of the compound 1 
was provided by the analysis of 1H NMR and 13C NMR data 
were presented in Table 1. 
RESULTS AND DISCUSSION 
Identification of Active Compound 
During chemical analysis the chloroform extract of C. 
ternatea flowers was separated by column chromatography 
with ethyl acetate as eluents to yield compound 1. The NMR 
spectrum of compound 1 showed similarities to those of the 
previously isolated cephalotaxine and cephalotaxinone 
skeleton 2, 3. Compound 1 was isolated as colorless needles 
(mp 158-160°C) with a specific rotation of [α]20D= −59.0 (c = 
0.30 in CHCl3). The GC-MS spectrum showed a molecular ion 
peak at m/e 312.97, which in accordance with the molecular 
formula of C18H19NO4 (MW 313). This molecular formula 
was deduced from the elemental analysis as follows, anal. C - 
68.85 (calcd, 68.94); H - 6.42 (calcd, 6.17); N - 4.49 (calcd, 
4.65) %. The UV-VIS spectrum in MeOH displayed 
absorption bands at 240 and 288 nm. The IR spectrum 
indicates the presence of C-H stretching (-OCH3) within the 
region of 2800-3000 cm-1, C-C stretching at 1448, 1060 and 
1015 cm-1, C-O-C stretching at 1230 cm-1 and 920 cm-1, N-C-
H at 3288 cm-1, C-N stretching at 1107 cm-1, and C=C 
stretching frequency at 1646 cm-1. The 13CNMR spectra of 1 
suggested the five-membered spiro-fused ring annular to the 
benzazepine skeleton, and it has shown 18 resonance signals 
due to the cephalotaxine system (Fig. 1). The chemical shifts 
and coupling constants of the 1H NMR data indicated that 
two aromatic signals were observed at (δH 6.63, H-14 and 
6.66, H-17) and the doublet at δH 5.88 ppm (d, 2H, J = 1.5 
Hz), integrating for two protons was assigned as the 
methylenedioxy group shows that the second aromatic ring 
was totally substituted 1, 15.  Compound 1 further showed 
one-proton singlet at δ 4.90 (1H, s, H-1), which is identified 
as an olefinic proton, thus confirming the presence of a 
nonaromatic -C=C- linkage in the alkaloid. In addition, the 
methoxy group signals was present at δ 3.69 ppm (3H, s) 
and at δC 57.30 indicates that attached to an unsaturated 
carbon; which showed the carbon resonance at δC 186.30 (C-
2). Characteristic low-field signal appears at δ 4.70 (1H, d, J = 
6.6 Hz, H-3) and this proton is coupled to one whose signal 
appears at δ 4.03 (1H, J = 6.6 Hz, H-4) and the H-10 protons 
were easily assigned to the center of the AB resonance 
system located at δ 3.06 and δ 2.57 with a large coupling 
constant (J =13.7 and 5.9 Hz). The 1HNMR spectrum contains 
one more proton signal at δ 4.84 (H-11a), it implies that, the 
hydroxyl group in the C-3 in cephalotaxine is replaced by 
11th beta hydrogen by ether linkage in compound 1. The 
1HNMR data of compound 1 instantaneously notify that it 
refers to great similarities with compound cephalotaxine & 
cephalotaxinone, showing only differences in the H-3 and H-
11 proton signals 1, 16. The NMR spectra and chemical shift 
assignments for compounds 1 were summarized in Table 1. 
Therefore, the compound 1 was assigned the name 3-deoxy-
3, 11-epoxy cephalotaxine based on the above experimental 
spectroscopic data.  
Anti-bacterial activity  
The antibacterial activity of compound 1 isolated from C. 
ternatea was studied in two different concentrations (100 
and 200 µg/mL) and its methanol extract at 300 µg/mL 
against two pathogenic bacterial strains (Staphylococcus 
aureus and Escherichia coli) and two fungal strains 
(Aspergillus flavus and Candida albicans). All the bacterial 
and fungal strains were selected based on its application 
purpose for further formulation study. This plant was 
particularly used as a traditional remedy to treat vaginal 
infections and infertility. Vaginal infections are caused by a 
fungus C. albicans. The anti-bacterial and anti-fungal 
potential of the test samples were assessed in terms of zone 
inhibition of bacterial growth, and the results were 
compared with standards (Ciprofloxacin 30 µg/mL and 
Amphotericin – B 20 µg/mL). Test sample at 100 and 200 
µg/mL doses revealed moderate anti-bacterial activity in a 
zone of inhibition ranging from 10.0 to 16.0 mm to all 
pathogens (Table 2). The highest zone of inhibition (13.0 
and 12.0 mm) was shown by 1 at a dose of 200 µg/mL 
against E. coli and S. aureus strains and (16.0, 12.0 mm) 
against anti-fungal strains of C. albicans and A. flavus. The 
results revealed that in the methanol extract, the bacterial 
activity against E. coli and S. aureus shows inhibition zone 
measured at (9.0 and 8.0 mm) and against C. albicans and A. 
flavus at 8.0 and 7.0 mm. These observations may be due to 
the presence of biological active constituent and which is 
responsible for anti-bacterial and anti-fungal activities. 
Anti-inflammatory activity   
Inhibition of carrageenan induced inflammation in rats is 
one of the most suitable test procedures to screen anti-
inflammatory agents. The paw edema induced by 
carrageenan involves several chemical mediators such as 
histamine, serotonin, bradykinin, and prostaglandins 17. The 
intraperitoneal injection of the carrageenan produced an 
inflammatory edema which decreased gradually, reaching its 
maxima at the 4th hour after injection. In this study, the 
isolated compound 1 tested at doses of 100 and 200 mg / kg 
exhibited significant anti-inflammatory activity in 
carrageenan induced rat paw edema model (Table 3). The 
results indicated that at both dose levels (100 mg and 200 
mg / kg) of isolated compound 1 had significant anti-
inflammatory activity from 2nd hour onwards. Paw volume 
found to be reduced in both doses as compared to control 
group to rats. 200 mg / kg was more active than 100 mg / kg 
and caused significant inhibition in the development of paw 
edema on the 2nd, 3rd, 4th hours (3.43 ± 0.02, 3.06 ± 0.02 
and 2.92 ± 0.05) and at a dose of 100 mg / kg caused 
maximum inhibition (3.44 ± 0.02) of the paw volume at the 
4th hour. This shows a performance well comparable with 
the standard drug diclofenac sodium (10 mg / kg) treated 
group caused significant inhibition of oedema on the second, 
third and fourth hour (3.40 ± 0.03, 3.19 ± 0.01 and 2.86 ± 
0.06) after carrageenan injection. Also, after the 
administration of carrageenan with the methanol extract of 
C. ternatea at the dose of 300 mg / kg exerted a considerable 
inhibitory effect on paw edema in rats starting from the 2nd 
hour (3.58 ± 0.04). The maximum inhibition (2.99 ± 0.04) 
exhibited by the methanol extract was recorded in the 4th 
hour. In the carrageenan induced rat paw edema model, 3- 
deoxy-3, 11- epoxy cephalotaxine (1) showed a significant 
inhibitory effect on edema formation. This effect starts from 
the second hour and was maintained in all the inflammatory 
phases, suggesting that the main mechanism of action of the 
tested compound may involve prostaglandin biosynthesis 
pathway and may influence other mediators of 
inflammation.  
CONCLUSION 
Based on the results, we can conclude that chloroform 
extracts of C. ternatea is the good sources of 3-deoxy-3, 11-
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epoxy Cephalotaxine (1). The bioactive compound 1 isolated 
from this plant can be employed for antimicrobial activity, 
also for the treatment of various bacterial and fungal 
infections and to show pronounced anti-inflammatory 
effects after three hours of injection. In addition, these 
results provided an initial scientific validation of the 
widespread use of this plant as a medicine against microbial 
and inflammatory processes. 
  
Figure 1: Chemical structure of compound 1 
 
Table 1: 1H and 13CNMR data of 3-deoxy-3, 11-epoxy cephalotaxine (1) isolated from Clitoria    ternatea 
13C NMR (δ)  1H NMR (δ in ppm, J in Hz) 
Carbon  δC  H δH 
1 126.40 1 4.90 (1H, s) 
2 163.80 2 - 
3 74.81 3 4.70 (1H, d, J = 6.8 Hz) 
4 42.01 4 4.03 (1H, d, J = 6.8 Hz) 
5 64.10 5 - 
6 19.92 6 1.86 (1H, m, Ha) 
1.77 (1H, m, Hb) 
7 29.98 7 1.53 (1H, m, Ha) 
1.70 (1H, m, Hb) 
8 51.60 8         3.06 (1H, dd, J = 13.7, 5.9 Hz, Ha) 
2.57 (1H, m, Hb) 
10 54.28 10 3.06 (1H, dd, J = 13.7, 5.9 Hz, Ha) 
2.57 (1H, m, Hb) 
11 77.29 11 4.84 (1H d, J = 5.9, 1.6 Hz, Ha) 
12 131.10 12 - 
13 130.20 13 - 
14 113.20 14 6.63 (1H, s, aromatic) 
15 146.40 15 - 
16 145.80 16 - 
17 109.40 17 6.66 (1H, s, aromatic) 
18 100.84 18 5.88 (s, 2H, J = 1.5 Hz, OCH2O) 
OCH3 57.30 OCH3 3.69 (3H, s) 
    
 
Table 2: Anti-bacterial activity of 3-deoxy-3, 11-epoxy cephalotaxine (1) isolated from Clitoria ternatea 
S. No. Micro organisms 
Zone of inhibition mm in diameter (M ± SD) 
3-deoxy-3, 11-epoxy 
cephalotaxine 
Methanolic 
Extract 
 
 
Standard 
 
100 µg / mL 200 µg / mL  300 µg / mL 
*- 30 µg / mL 
**- 20 µg / mL 
1 Escherichia coli 11 ± 0.40 13 ± 0.70 09 ± 1.00 18 ± 1.20* 
2 Staphylococcus aureus 11 ± 0.70 12 ± 0.40 08 ± 0.40 17 ± 0.90* 
3 Aspergillus flavus 10 ± 0.10 12 ± 0.40 07 ± 0.60 12 ± 0.50** 
4 Candida albicans 11 ± 0.20 16 ± 0.70 08 ± 0.70 22 ± 0.60** 
Bacteria Standard* - Ciprofloxacin (30 µg / mL)  
Fungal Standard** - Amphotericin - B (20 µg / mL)  
Values are expressed in Mean ± Standard Deviation (M ± SD) (n=3) 
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Table 3: Anti-inflammatory activity of 3-deoxy-3, 11-epoxy cephalotaxine (1) isolated from    Clitoria ternatea 
S. No Treatment 
Anti-inflammatory activity (cm) (M ± SD) 
1 h 2 h 3 h 4 h 
1 Normal Control 2.33 ± 0.01 2.33 ± 0.01 2.32 ± 0.01 2.31 ± 0.05* 
2 1% carrageenan 3.81 ± 0.05 3.60 ± 0.16 3.52 ± 0.12 3.51 ± 0.04 
3 Diclofenac sodium (10 mg) 3.85 ± 0.08 3.40 ± 0.03  3.19 ± 0.01* 2.86 ± 0.06* 
4 3-deoxy-3, 11-epoxy cephalotaxine (100 mg) 3.75 ± 0.04 3.59 ± 0.03 3.48 ± 0.03 3.44 ± 0.02      
5 3-deoxy-3, 11-epoxy cephalotaxine (200 mg) 3.74 ± 0.04 3.43 ± 0.02 3.06 ± 0.02* 2.92 ± 0.05* 
6  Methanolic Extract (300 mg) 3.79 ± 0.03 3.58 ± 0.04  3.46 ± 0.04 2.99 ± 0.04 ⃰ 
Data presented above are mean ± standard deviation (M ± SD) values of three replicates. *p < 0.05 compared to control 
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